We describe a case of blinatumomab-associated neurologic event (NE) and highlight the diagnostic complexity in differentiating neurotoxicity versus acute cerebrovascular disease (CVD) in patients with cancer.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: